ScoreWhy is Shanghai Runda Medical Technology Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 8.23%
- The company has been able to generate a Return on Capital Employed (avg) of 8.23% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of -2.66% and Operating profit at -175.28% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 12.29% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of -2.66% and Operating profit at -175.28% over the last 5 years
4
Flat results in Jun 26
- NET PROFIT(9M) At CNY -473.57 MM has Grown at -308.97%
- NET SALES(9M) At CNY 4,923.78 MM has Grown at -12.17%
- INVENTORY TURNOVER RATIO(HY) Lowest at 3.36 times
5
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -39.38%, its profits have fallen by -770%
- At the current price, the company has a high dividend yield of 0.3
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Shanghai Runda Medical Technology Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Shanghai Runda Medical Technology Co., Ltd.
-37.49%
-0.70
48.42%
China Shanghai Composite
3.23%
0.23
14.72%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-2.66%
EBIT Growth (5y)
-175.28%
EBIT to Interest (avg)
1.68
Debt to EBITDA (avg)
17.13
Net Debt to Equity (avg)
1.29
Sales to Capital Employed (avg)
0.74
Tax Ratio
10.52%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.00%
ROE (avg)
12.29%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.50
EV to EBIT
-54.96
EV to EBITDA
127.33
EV to Capital Employed
1.20
EV to Sales
1.64
PEG Ratio
NA
Dividend Yield
0.32%
ROCE (Latest)
-2.18%
ROE (Latest)
-13.50%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend11What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -23.22% (YoY
OPERATING PROFIT(Q)
Highest at CNY 198.98 MM
OPERATING PROFIT MARGIN(Q)
Highest at 11.82 %
PRE-TAX PROFIT(Q)
Highest at CNY 13.99 MM
NET PROFIT(Q)
Highest at CNY -34.31 MM
EPS(Q)
Highest at CNY -0.06
-11What is not working for the Company
NET PROFIT(9M)
At CNY -473.57 MM has Grown at -308.97%
NET SALES(9M)
At CNY 4,923.78 MM has Grown at -12.17%
INVENTORY TURNOVER RATIO(HY)
Lowest at 3.36 times
INTEREST(Q)
Highest at CNY 76.75 MM
Here's what is working for Shanghai Runda Medical Technology Co., Ltd.
Pre-Tax Profit
At CNY 13.99 MM has Grown at 112.18%
over average net sales of the previous four periods of CNY -114.81 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Operating Profit
Highest at CNY 198.98 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CNY MM)
Operating Profit Margin
Highest at 11.82 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at CNY 13.99 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY -34.31 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Net Profit
At CNY -34.31 MM has Grown at 74.24%
over average net sales of the previous four periods of CNY -133.17 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY -0.06
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Raw Material Cost
Fallen by -23.22% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Shanghai Runda Medical Technology Co., Ltd.
Interest
At CNY 76.75 MM has Grown at 25.95%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Inventory Turnover Ratio
Lowest at 3.36 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Net Sales
At CNY 4,923.78 MM has Grown at -12.17%
Year on Year (YoY)MOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Interest
Highest at CNY 76.75 MM
in the last five periods and Increased by 25.95% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Footer loading
